GlassScriptPhysician profile
Peter J Sardella
NPI 1114019551
$4,471.94
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $396 · 2021: $69.06 · 2022: $1,466 · 2023: $1,942 · 2024: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,179 · Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,179.22 |
| Food and Beverage | $1,138.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,496.66 | 2022-2023 | |
| Musculoskeletal Transplant Foundation INC. | $353.38 | 2020 | |
| Biotissue Holdings INC. | $302.57 | 2023-2024 | |
| Smith+Nephew, INC. | $247.38 | 2019-2024 | Grafix Pl, Stravix, Collagenase Santyl |
| Linvatec Corporation | $139.09 | 2024 | Biobrace 23mm, Allograft Tissue |
| Paratek Pharmaceuticals, INC. | $93.36 | 2022-2024 | Nuzyra |
| Wright Medical Technology, INC. | $88.67 | 2019 | |
| Dynasplint Systems INC. | $83.97 | 2022 | |
| Nevro Corp. | $81.01 | 2022-2023 | Senza |
| Osteomed LLC | $64.63 | 2019-2022 | |
| Orthofix Medical, INC. | $62.56 | 2022-2024 | Physio-Stim |
| Integra Lifesciences Corporation | $60.81 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acumed LLC | $49.92 | 2022 | |
| Bioventus LLC | $49.56 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $36.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $35.39 | 2023-2024 | Tirosint, Licart, Tirosint |
| Kowa Pharmaceuticals America, INC. | $30.51 | 2022-2023 | Seglentis |
| Ani Pharmaceuticals, INC. | $28.27 | 2023 | Purified Cortrophin Gel |
| Averitas Pharma INC. | $24.03 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $18.27 | 2021 | |
| Organogenesis INC. | $17.90 | 2022 | |
| Amgen INC. | $17.55 | 2024 | Krystexxa |
| Misonix INC | $17.20 | 2019 | |
| Reprise Biomedical, INC. | $15.62 | 2024 | Miro3d |
| Tactile Systems Technology INC | $15.51 | 2023 | Flexitouch Plus, Entre Plus |
| Solventum Corporation | $14.51 | 2024 | Activ.A.C. |
| Kci USA, INC. | $13.86 | 2022 | |
| Sebela Pharmaceuticals INC. | $13.28 | 2023 | Naftin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Sardella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.